Liver Arginase 抗体
(Arginase, Liver (ARG1))
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exist (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| Liver Arginase 抗体 | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| Recombinant Liver Arginase 抗体 (Arg1) | 人 | 兔 Monoclonal |
|
|
|
| Liver Arginase 抗体 (AA 1-236) | 人, 小鼠, 大鼠 | 小鼠 Monoclonal |
|
|
|
| Liver Arginase 抗体 | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| Liver Arginase 抗体 (AA 1-322) (Carboxyfluorescein (CFS)) | 人 | 绵羊 Polyclonal |
|
|
|
| Liver Arginase 抗体 (AA 1-322) | 人 | 兔 Polyclonal |
|
|
|
| Liver Arginase 抗体 (AA 292-318) | 人, 大鼠 | 兔 Polyclonal |
|
|
|
| Liver Arginase 抗体 (AA 46-95) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant Liver Arginase 抗体 | 人 | 兔 Monoclonal |
|
|
|
| Recombinant Liver Arginase 抗体 | 大鼠 | 兔 Monoclonal |
|
|
|
| Liver Arginase 抗体 (N-Term) | 人, 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| Liver Arginase 抗体 (AA 307-323) | 小鼠, 大鼠 | 兔 Polyclonal |
|
|
|
| Liver Arginase 抗体 (AA 1-150) | 人 | 小鼠 Monoclonal |
|
|
|
| Liver Arginase 抗体 (AA 292-318) | 大鼠 | 兔 Polyclonal |
|
|
|
| Liver Arginase 抗体 | 人, 小鼠, 大鼠 | 兔 Monoclonal |
|
|
|
| Rockland Original | Liver Arginase 抗体 | Cow | 兔 Polyclonal |
|
|
| Rockland Original | Liver Arginase 抗体 (HRP) | Cow | 兔 Polyclonal |
|
|
| Rockland Original | Liver Arginase 抗体 | Cow | 兔 Polyclonal |
|
|
| Liver Arginase 抗体 (AA 1-150) | 人 | 小鼠 Monoclonal |
|
|
|
| Liver Arginase 抗体 (C-Term) | 人 | 小鼠 Monoclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- ARG1-7514R
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
- 抗原表位
- AA 200-322, Arg1
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 4A0
- 标记
- unconjugated
- 抗体亚型
- IgG2a
- 抗原表位
- AA 1-236
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 绵羊
- 克隆形成能力
- Polyclonal
- 标记
- Carboxyfluorescein (CFS)
- 抗体亚型
- IgG
- 抗原表位
- AA 1-322
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-322
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 292-318
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 46-95
Primary Antibody
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- 31D1231D12
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- R03-6I4
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 307-323
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (Immunohistochemistry: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- ARG1-1125
- 标记
- unconjugated
- 抗体亚型
- IgG3, kappa
- 抗原表位
- AA 1-150
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- Ig Fraction
- 抗原表位
- AA 292-318
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- ADG-1
- 标记
- unconjugated
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- Supplier Product No.
- Rockland 100-4142
- 适用
- Cow
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
Rockland Original
Primary Antibody
- DB (Dot Blot: 有验证图片)
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- Supplier Product No.
- Rockland 200-4342-0100
- 适用
- Cow
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
Rockland Original
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- Supplier Product No.
- Rockland 200-4142-0100
- 适用
- Cow
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
Rockland Original
Primary Antibody
- WB (Western Blotting: 有验证图片)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- ARG1-1125
- 标记
- unconjugated
- 抗体亚型
- IgG3, kappa
- 抗原表位
- AA 1-150
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 质量等级
- Carrier-free
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- T1ARG-1
- 标记
- unconjugated
- 抗体亚型
- IgG3, kappa
- 抗原表位
- C-Term
Latest Publications for our Liver Arginase 抗体
: "The HIV protease inhibitor Saquinavir attenuates sepsis-induced acute lung injury and promotes M2 macrophage polarization via targeting matrix metalloproteinase-9." in: Cell death & disease, Vol. 12, Issue 1, pp. 67, (2021) (PubMed).
: "Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis." in: Theranostics, Vol. 10, Issue 16, pp. 7319-7334, (2021) (PubMed).
: "AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization." in: Theranostics, Vol. 10, Issue 26, pp. 12011-12025, (2021) (PubMed).
: "Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors." in: Molecular therapy oncolytics, Vol. 17, pp. 431-447, (2020) (PubMed).
: "Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing α-ketoglutarate production in mice." in: Molecular oral microbiology, Vol. 33, Issue 5, pp. 388-395, (2019) (PubMed).
: "IL-6 mediates ER expansion during hyperpolarization of alternatively activated macrophages." in: Immunology and cell biology, Vol. 97, Issue 2, pp. 203-217, (2019) (PubMed).
: "Concerted IL-25R and IL-4Rα signaling drive innate type 2 effector immunity for optimal helminth expulsion." in: eLife, Vol. 7, (2019) (PubMed).
: "Peroxisome Proliferator-Activated Receptor γ Is Essential for the Resolution of Staphylococcus aureus Skin Infections." in: Cell host & microbe, Vol. 24, Issue 2, pp. 261-270.e4, (2019) (PubMed).
: "A novel Microproteomic Approach Using Laser Capture Microdissection to Study Cellular Protrusions." in: International journal of molecular sciences, Vol. 20, Issue 5, (2019) (PubMed).
: "Immunoregulation of macrophages by dynamic ligand presentation via ligand-cation coordination." in: Nature communications, Vol. 10, Issue 1, pp. 1696, (2019) (PubMed).
: "Sulforaphane elicts dual therapeutic effects on Renal Inflammatory Injury and crystal deposition in Calcium Oxalate Nephrocalcinosis." in: Theranostics, Vol. 10, Issue 16, pp. 7319-7334, (2021) (PubMed).
: "AhR activation attenuates calcium oxalate nephrocalcinosis by diminishing M1 macrophage polarization and promoting M2 macrophage polarization." in: Theranostics, Vol. 10, Issue 26, pp. 12011-12025, (2021) (PubMed).
: "Sindbis Virus with Anti-OX40 Overcomes the Immunosuppressive Tumor Microenvironment of Low-Immunogenic Tumors." in: Molecular therapy oncolytics, Vol. 17, pp. 431-447, (2020) (PubMed).
: "Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing α-ketoglutarate production in mice." in: Molecular oral microbiology, Vol. 33, Issue 5, pp. 388-395, (2019) (PubMed).
: "IL-6 mediates ER expansion during hyperpolarization of alternatively activated macrophages." in: Immunology and cell biology, Vol. 97, Issue 2, pp. 203-217, (2019) (PubMed).
: "Concerted IL-25R and IL-4Rα signaling drive innate type 2 effector immunity for optimal helminth expulsion." in: eLife, Vol. 7, (2019) (PubMed).
: "Peroxisome Proliferator-Activated Receptor γ Is Essential for the Resolution of Staphylococcus aureus Skin Infections." in: Cell host & microbe, Vol. 24, Issue 2, pp. 261-270.e4, (2019) (PubMed).
: "A novel Microproteomic Approach Using Laser Capture Microdissection to Study Cellular Protrusions." in: International journal of molecular sciences, Vol. 20, Issue 5, (2019) (PubMed).
: "Immunoregulation of macrophages by dynamic ligand presentation via ligand-cation coordination." in: Nature communications, Vol. 10, Issue 1, pp. 1696, (2019) (PubMed).
Aliases for Liver Arginase 抗体
arginase 1 (arg1) 抗体arginase (PGTG_16455) 抗体
Arginase-1 (argi1) 抗体
arginase 1 (ARG1) 抗体
arginase, liver (Arg1) 抗体
arginase 1 (Arg1) 抗体
L-arginase (arg1) 抗体
AI 抗体
AI256583 抗体
Arg-1 抗体
argi1 抗体
PGIF 抗体
si:ch211-146f4.3 抗体
SI:zC146F4.4 (novel protein with NUDIX domain) 抗体
您还需要查找其他产品吗？
You are here:
